Pharma

The investment comes less than a year after the company launched with $9 million in funding, bringing its total raise to more than $25 million.

This is the latest in its string of acquisitions to expand its digital health portfolio.

The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.

Hackers may have entered through one of its third-party vendors.

The pharma giant's employees will have access to ChatGPT Enterprise, which allows teams to create customized GPTs on specific topics.

Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.

Gee Mathen, director of pharmacy clinical applications and technical services at Texas Children's Hospital, discusses his upcoming HIMSS24 session "Combating Counterfeit Drugs and the Drug Supply Chain Security Act."

The company will use the funds to create and launch new products, expand its network and speed up its growth.

Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.   

The company will offer a customizable version of its Marketplace Search Technology to health plans supporting Medicare beneficiaries.